Showing results (1121-1130 of 1,767) with videos related to

Sort By:
Pageof 177
JAMA Neurology|January 20, 2016
Physiotherapy and Occupational Therapy vs No Therapy in Mild to Moderate Parkinson Disease: A Randomized Clinical TrialCarl E Clarke, Smitaa Patel, Natalie Ives, et al.
JAMA Neurology|August 11, 2015
Cerebrospinal Fluid Patterns and the Risk of Future Dementia in Early, Incident Parkinson DiseaseDavid C Bäckström, Magdalena Eriksson Domellöf, Jan Linder, et al.
JAMA Neurology|August 25, 2015
Nerve Growth Factor Gene Therapy: Activation of Neuronal Responses in Alzheimer DiseaseMark H Tuszynski, Jennifer H Yang, David Barba, et al.
JAMA Neurology|August 18, 2015
Effect of Presymptomatic Body Mass Index and Consumption of Fat and Alcohol on Amyotrophic Lateral SclerosisMark H B Huisman, Meinie Seelen, Perry T C van Doormaal, et al.
JAMA Neurology|December 16, 2014
Evolution of prodromal clinical markers of Parkinson disease in a GBA mutation-positive cohortMichelle Beavan, Alisdair McNeill, Christos Proukakis, et al.
JAMA Neurology|December 16, 2014
Massive CAG repeat expansion and somatic instability in maternally transmitted infantile spinocerebellar ataxia type 7Heather Trang, Sabrina Y Stanley, Paul Thorner, et al.
JAMA Neurology|December 2, 2014
Investigations on CXCL13 in anti-N-methyl-D-aspartate receptor encephalitis: a potential biomarker of treatment responseFrank Leypoldt, Romana Höftberger, Maarten J Titulaer, et al.
JAMA Neurology|January 20, 2015
Cognitive resilience to apolipoprotein E ε4: contributing factors in black and white older adultsAllison R Kaup, Jasmine Nettiksimmons, Tamara B Harris, et al.
JAMA Neurology|December 23, 2014
Rarity of the Alzheimer disease-protective APP A673T variant in the United StatesLi-San Wang, Adam C Naj, Robert R Graham, et al.
JAMA Neurology|December 23, 2014
Evaluation of no evidence of disease activity in a 7-year longitudinal multiple sclerosis cohortDalia L Rotstein, Brian C Healy, Muhammad T Malik, et al.
Pageof 177